ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 73

Fibrillin-1 Expression and Function Is Needed For Normal Joint Function and Mutations Leads To Osteoarthritis

Wasabha Ramanayake1, Helen Jones1, Isabel Orriss2, Tim Arnett2, Andrew Pitsillides3, Christopher P. Denton4, David J. Abraham4 and Blandine Poulet5, 1Centre for Rheumatology and Connective tissue diseases, UCL Medical School, London, United Kingdom, 2Department of Cell and developmental biology, University College London, London, United Kingdom, 3Department of Comparative Biomedical Sciences, Royal Veterniary College, London, United Kingdom, 4Centre for Rheumatology and Connective Tissue Diseases, UCL Medical School, London, United Kingdom, 5Centre for Rheumarology and connective tissue diseases, UCL Medical School, London, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Knee, mouse model and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Title: Biology and Pathology of Bone and Joint (Cartilage and Osteoarthritis)

Session Type: Abstract Submissions (ACR)

Background/Purpose: Osteoarthritis (OA) is a common degenerative disease leading to pain and disability in >6million british people. The TGFb signalling pathway has been shown to play a major role in joint homeostasis and in OA development. Fibrillin-1 is an extracellular matrix protein that may play a structural role in the matrix of articular cartilage, but also regulates the bioavailability of TGFb to the cell. Thus Fibrillin-1 mutations, such as those seen in the Tight Skin mouse (or TSK), have been shown to increase TGFb signalling. The aim of this study is therefore to determine changes in fibrillin-1 expression during osteoarthritis in mice and to characterise the effect of Fibrillin-1 mutations in ageing-induced OA development in TSK mice.

Methods: Immunohistochemistry for Fibrillin-1 expression was performed in Str/ort mice, a known model of spontaneous OA, and in control aged-matched non-OA CBA mice, in knee joints with different degrees of OA severity. The knees of TSK and littermate control male mice of 60-80wks of age were fixed and microCT scanned. Abnormal ectopic calcified regions were analysed. After scanning, joints were decalcified and processed for paraffin embedding; serial coronal sections were cut at 6um and sections at regular intervals stained with Toluidine Blue.

Results: Fibrillin-1 was localised in the pericellular matrix of articular chondrocytes in normal joints. During the development of OA in Str/ort mice, however, Fibrillin-1 immunolabelling was decreased, in particular around articular cartilage lesions. TSK mice microCT images showed important ectopic calcification in various ligaments, as well as osteophyte formation on the margins of the joints. Preliminary data suggest that articulate cartilage degradation was increased in TSK mice compared to aged-matched control mice.

Conclusion: Our preliminary study shows that Fibrillin-1 protein expression is decreased during OA development in a well known model of spontaneous OA, suggesting TGFb bioavailability may be modified during this period. In addition, mutations in Fibrillin-1 in the TSK mouse lead to abnormal ossification in the knee joint as well as severe OA development. These data suggest that Fibrillin-1 plays an important role in joint homeostasis and that abnormal expression or mutations in its gene can lead to OA development.


Disclosure:

W. Ramanayake,
None;

H. Jones,
None;

I. Orriss,
None;

T. Arnett,
None;

A. Pitsillides,
None;

C. P. Denton,
None;

D. J. Abraham,
None;

B. Poulet,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/fibrillin-1-expression-and-function-is-needed-for-normal-joint-function-and-mutations-leads-to-osteoarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology